Extended Underperformance Against Market Benchmarks
Kobo Biotech’s recent price action is part of a longer-term pattern of underperformance relative to the broader market. Over the past month, the stock has declined by 28.74%, while the Sensex has gained 1.34%. This divergence is even more pronounced over the one-year and three-year horizons, with the stock falling 15.33% and 53.36% respectively, compared to Sensex gains of 5.27% and 35.37%. Over five years, the stock has lost 63.46% of its value, whereas the Sensex has nearly doubled, rising 90.68%. These figures underscore a persistent weakness in Kobo Biotech’s share price relative to the benchmark index, signalling structural challenges or lack of investor confidence in the company’s prospects.
Technical In...
Read More











